What are the potential side effects of methylene blue?

Potential Side Effects of Methylene Blue

Methylene blue carries several serious and potentially life-threatening side effects that clinicians must recognize before administration, most critically: severe hemolytic anemia in G6PD deficiency patients, serotonin syndrome when combined with serotonergic medications, and paradoxical worsening of methemoglobinemia at high doses. 1

Critical High-Risk Side Effects

Hemolytic Anemia in G6PD Deficiency

• Methylene blue is absolutely contraindicated in patients with G6PD deficiency 1
• Can cause severe Heinz body hemolytic anemia even at therapeutic doses
• The drug is both ineffective AND harmful in this population because:
  • G6PD-deficient patients cannot produce sufficient NADPH to convert methylene blue to its active reducing form (leukomethylene blue)
  • At doses ≥4 mg/kg, the oxidizing form predominates over the reducing form, directly causing hemolysis
• Critical pitfall: Hemolysis can occur even in patients with normal G6PD activity when excessive doses are used 2
• Action required: Test all patients for G6PD deficiency before administration; if emergency treatment is needed, obtain family history of G6PD deficiency 1

Serotonin Syndrome

• Occurs when methylene blue is given to patients taking SSRIs or other serotonergic antidepressants 1, 3
• Mechanism: Methylene blue acts as a potent monoamine oxidase inhibitor (MAOI) 1, 4
• Can occur at doses as low as 1 mg/kg IV 4
• Severity ranges from mild to severe; one fatality has been reported 3
• Critical finding: Even oral methylene blue (in urinary analgesics) can precipitate serotonin syndrome 3
• Action required: Carefully review all medications before methylene blue administration; strongly consider stopping serotonergic drugs before use 4

Paradoxical Worsening of Methemoglobinemia

• Risk increases with repeated doses; toxic levels reached at total dose >7 mg/kg 1
• Rebound phenomenon: Methemoglobin levels may increase after treatment completion 1
• Action required: If methemoglobinemia worsens after methylene blue treatment, perform urgent exchange transfusion 1

Pregnancy and Neonatal Risks

• Use with extreme caution in pregnant women 1
• Concerns include:
  • Teratogenicity
  • Possible intestinal atresia
• In premature infants (doses 2-4 mg/kg):
  • Can cause hemolysis even in non-G6PD-deficient infants 1
  • Can paradoxically cause methemoglobinemia 1

Cardiovascular Effects

• In anesthetized patients or those with renal failure, use cautiously 1
• Mechanism: Inhibits guanylate cyclase, decreasing nitric oxide-mediated vasodilation
• Results in systemic and pulmonary hypertension 1

Tissue Toxicity

• Retinal toxicity: Inadvertent intraocular injection causes profound vision loss and inner retinal damage 5
• This represents a "never event" from medication errors (confusion with trypan blue or brilliant blue in ophthalmic surgery)

Common/Minor Side Effects

While the guidelines focus primarily on serious adverse effects, the evidence suggests methylene blue is generally well-tolerated when used appropriately, with the major risks being the contraindications and drug interactions listed above rather than common minor side effects.

Dosing-Related Safety

• Standard therapeutic dose: 1-2 mg/kg IV over 3-5 minutes 1
• May repeat at 1 mg/kg if needed after 30-60 minutes
• Never exceed 7 mg/kg total dose 1
• For continuous infusion: 0.10-0.25 mg/kg/hr 1

Key Clinical Decision Points

1. Before any methylene blue administration:

   • Screen for G6PD deficiency (or obtain family history in emergencies)
   • Review all medications for serotonergic agents
   • Assess pregnancy status
   • Evaluate renal function
   • Consider anesthesia status

2. If contraindications exist, use alternative treatments:

   • Ascorbic acid (vitamin C) for G6PD-deficient patients 1
   • Exchange transfusion for severe cases 1